A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure–function results of A-ring modified Vitamin D sterols

作者: Mathew T. Mizwicki , Craig. M. Bula , June E. Bishop , Anthony W. Norman

DOI: 10.1016/J.JSBMB.2005.06.025

关键词:

摘要: The steroid hormone 1alpha,25(OH)(2)-Vitamin D(3) (1,25D) activates both genomic and non-genomic intracellular signaling cascades. It is also well recognized that co-incubation of 1,25D with its C-1 epimer, 1beta,25D (HL), suppresses the efficiency signal activated by alone C-3 3alpha-1,25D (HJ) nearly as potent in suppressing PTH secretion, believed to be propagated 1,25D's signaling. Both these sterols lack hypercalcemic effect induced pharmacological doses have reduced VDR affinity compared 1,25D, measured a competition assay. Recent functional studies suggest required for Along lines we recently proposed Vitamin D sterol/VDR conformational ensemble model posits contains two distinct, yet overlapping ligand binding sites, potential differential stabilities HL pockets can used explain their different properties. region predominantly occupied sterol's A-ring when it bound either pocket (G-pocket), defined X-ray crystallography, or alternative (A-pocket), discovered using silico techniques (directed docking). Therefore, gain further insight into application this docked other diastereomer [(1beta,3alpha)=HH] 1- 3-deoxy forms (25D CF, respectively) A- G-pockets assess pockets, relative 1,25D. models were then provide putative mechanistic arguments known structure-function experimental results. This may new insights how uncouple unwanted from attractive growth inhibitory/differentiation properties do so differentially stabilizing subpopulations members.

参考文章(65)
A.W. Norman, R Bouillon, M.C. Farach-Carson, J.E. Bishop, L.X. Zhou, I Nemere, J Zhao, K.R. Muralidharan, W.H. Okamura, Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. Journal of Biological Chemistry. ,vol. 268, pp. 20022- 20030 ,(1993) , 10.1016/S0021-9258(20)80689-9
Wayne R. Wecksler, Anthony W. Norman, Structural aspects of the binding of 1 alpha, 25-dihydroxyvitamin D3 to its receptor system in chick intestine. Methods in Enzymology. ,vol. 67, pp. 494- 500 ,(1980) , 10.1016/S0076-6879(80)67061-X
Daniel D. Bikle, Vitamin D and skin cancer. Journal of Nutrition. ,vol. 134, ,(2004) , 10.1093/JN/134.12.3472S
H Sekimoto, M.-L Siu-Caldera, A Weiskopf, P Vouros, K.R Muralidharan, W.H Okamura, M.R Uskokovic, G.S Reddy, 1α,25-Dihydroxy-3-epi-vitamin D3: In vivo metabolite of 1α,25-dihydroxyvitamin D3 in rats FEBS Letters. ,vol. 448, pp. 278- 282 ,(1999) , 10.1016/S0014-5793(99)00377-4
Sonoko MASUDA, Maya KAMAO, Neil J. SCHROEDER, Hugh L.J. MAKIN, Glenville JONES, Richard KREMER, Johng RHIM, Toshio OKANO, Characterization of 3-epi-1α, 25-dihydroxyvitamin D3 involved in 1α, 25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines Biological & Pharmaceutical Bulletin. ,vol. 23, pp. 133- 139 ,(2000) , 10.1248/BPB.23.133
Maya KAMAO, Syuichiro TATEMATSU, G Satyanarayana REDDY, Susumi HATAKEYAMA, Makiko SUGIURA, Noriko OHASHI, Noboru KUBODERA, Toshio OKANO, Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106). Journal of Nutritional Science and Vitaminology. ,vol. 47, pp. 108- 115 ,(2001) , 10.3177/JNSV.47.108
Toshie Fujishima, Katsuhiro Konno, Kimie Nakagawa, Mayuko Kurobe, Toshio Okano, Hiroaki Takayama, Efficient synthesis and biological evaluation of all A-ring diastereomers of 1α, 25-dihydroxyvitamin D3 and its 20-epimer Bioorganic & Medicinal Chemistry. ,vol. 8, pp. 123- 134 ,(2000) , 10.1016/S0968-0896(99)00262-X
M.G. Bischof, M.-L. Siu-Caldera, A. Weiskopf, P. Vouros, H.S. Cross, M. Peterlik, G.S. Reddy, Differentiation-Related Pathways of 1α,25-Dihydroxycholecalciferol Metabolism in Human Colon Adenocarcinoma-Derived Caco-2 Cells: Production of 1α,25-Dihydroxy-3epi-cholecalciferol Experimental Cell Research. ,vol. 241, pp. 194- 201 ,(1998) , 10.1006/EXCR.1998.4044